(Q42281538)

English

DAU 6215, a novel 5-HT3-receptor antagonist, selectively antagonizes scopolamine-induced deficit in a passive-avoidance task, but not scopolamine-induced hypermotility in rats

scientific article published on September 1993

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 October 2017

DAU 6215, a novel 5-HT3-receptor antagonist, selectively antagonizes scopolamine-induced deficit in a passive-avoidance task, but not scopolamine-induced hypermotility in rats (English)

1 reference

Europe PubMed Central

19 October 2017

1 reference

based on heuristic

inferred from title

author name string

A Brambilla

1

1 reference

Europe PubMed Central

19 October 2017

A Ghiorzi

2

1 reference

Europe PubMed Central

19 October 2017

N Pitsikas

3

1 reference

Europe PubMed Central

19 October 2017

F Borsini

4

1 reference

Europe PubMed Central

19 October 2017

publication date

1 September 1993

1 reference

Europe PubMed Central

19 October 2017

Journal of Pharmacy and Pharmacology

1 reference

Europe PubMed Central

19 October 2017

45

1 reference

Europe PubMed Central

19 October 2017

9

1 reference

Europe PubMed Central

19 October 2017

841-843

1 reference

Europe PubMed Central

19 October 2017

Enhancement of the memory of a previously learned aversive habit following pre-test administration of a variety of serotonergic antagonists in mice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05698.X

21 January 2018

The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05698.X

21 January 2018

Evidence for a direct cholinergic involvement in the scopolamine-induced amnesia in monkeys: Effects of concurrent administration of physostigmine and methylphenidate with scopolamine

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05698.X

21 January 2018

Enhancement of memory retrieval and attenuation of scopolamine-induced amnesia following administration of 5-HT3 antagonist ICS 205-930

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05698.X

21 January 2018

Memory enhancing effects of granisetron (BRL 43694) in a passive avoidance

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05698.X

21 January 2018

Disruption of memory produced by stimulation of the dorsal raphe nucleus: mediation by serotonin

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05698.X

21 January 2018

Mechanism of action of scopolamine as an amnestic

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05698.X

21 January 2018

Serotonin, memory, and the aging brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05698.X

21 January 2018

Psychopharmacological strategies in the search for cognition enhancers

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05698.X

21 January 2018

5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1993.TB05698.X

21 January 2018

Identifiers

10.1111/J.2042-7158.1993.TB05698.X

1 reference

Europe PubMed Central

19 October 2017

1 reference

Europe PubMed Central

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42281538&oldid=1940994847"